Research Project · Health
Diagnostics Accelerator: Biobank Sharing RFP
Alzheimer's Drug Discovery Foundationwww.alzdiscovery.org (opens in a new tab)Catalog updated
- Amount
- Not listed
- Program type
- Research Project
- Field
- Health
- Eligible career stages
- Not listed
About this program
The Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator Biobank Sharing RFP supports proof-of-principle and validation studies of Alzheimer’s disease and related dementia biomarkers using shared plasma, serum, whole blood, and cerebrospinal fluid samples. Proposals must demonstrate biological rationale, established assay methodology, analytical and clinical supporting data, a defined FDA context of use, power and statistical analyses, and plans for reproducibility, regulatory advancement, scalability, and commercialization. Researchers and clinicians worldwide at universities, academic medical centers, nonprofits, and for-profit companies are eligible, with industry partnerships encouraged. Applicants must first submit a Letter of Intent through the ADDF Funding Portal; proposals requesting both funding and samples should apply through the Peripheral Biomarkers Program.
In FundFit
FundFit names the researchers at your institution who match this program, and shows the eligibility rules, the announcement, and 50 or more similar programs in full.
Ask for a demo of this program The form opens already filled in.